Introduction
Many countries have tracked changing demographics, with projections suggesting the world’s population of adults 60 and older will double to 22% (2 billion) by 2050. With increasing longevity have come higher rates of morbidity owing to chronic disease, with 80% of older adults having at least one chronic condition and 40% having two or more. This coexistence of chronic systemic diseases has been termed multimorbidity.
Treating patients with mult-imorbidities requires personalized approaches that account for individual variations in disease susceptibility, treatment response, and systemic health interactions. Precision medicine—which tailors prevention, diagnosis, and treatment to each patient’s unique biological, genetic, and environmental characteristics—provides frameworks to move beyond population averages to individualized care protocols. Its application to geriatric oral health represents an emerging frontier with immediate clinical relevance for dental practitioners managing complex older adult patients.
Genomics and Pharmacogenomics
Genomic analysis has revealed that genetic variations significantly influence susceptibility to common oral diseases. Specific genetic polymorphisms in genes such as IL-1, IL-6, and TNF-α have been associated with increased risk for severe periodontitis. Multi-omics integration with advanced imaging techniques enhances diagnostic precision and treatment planning in dentistry.
Perhaps more immediately applicable for practitioners is pharmacogenomics—the study of how genetic variations affect drug responses. Older adults frequently present with complex medication regimens, and pharmacogenomic testing can optimize drug selection to minimize adverse effects. Genetic variations in cytochrome P450 enzymes significantly affect metabolism of analgesics, local anesthetics, and sedatives used in dental procedures. Identifying patients who are poor metabolizers or ultra-rapid metabolizers allows for dose adjustments that enhance both safety and effectiveness—critical given that adverse drug reactions occur up to seven times more frequently in older adults.
Treatment Implications
Pharmacogenomic testing should be considered for older patients with polypharmacy, particularly when planning sedation procedures or prescribing opioid analgesics. Current evidence demonstrates that genotyping for CYP2D6 and CYP2C19 variants can guide individualized dosing of common dental medications. Although point-of-care genetic testing is not yet widely available in dental settings, collaboration with the patient’s physician or pharmacist to obtain existing pharmacogenomic data from their medical record can inform safer prescribing practices. When pharmacogenomic information is unavailable, practitioners should apply conservative dosing principles with careful monitoring, especially in patients with hepatic or renal impairment.
Oral Microbiome and Dysbiosis
The oral cavity harbors over 700 bacterial species. In older adults, the oral microbiome undergoes significant age-related changes influenced by reduced salivary flow, dietary modifications, medication use, and declining immune function. These alterations can lead to dysbiosis—an imbalance promoting disease.
Recent advances in microbiome profiling reveal that oral dysbiosis extends beyond local oral disease, with profound systemic health implications. Studies have demonstrated associations between specific oral microbiome signatures and conditions including Alzheimer’s disease, cardiovascular disease, diabetes, and respiratory infections—conditions disproportionately affecting older adults.
https://ostrowonline.usc.edu/are-older-adults-more-vulnerable-to-oral-systemic-link/The bidirectional relationships between oral health and systemic conditions are particularly relevant in geriatric populations. In older adults living with human immunodeficiency virus, the risk for drug-drug interactions is especially great owing to the multidrug regimen needed, as well as other medications to treat conditions frequently seen in aging.
Treatment Implications
For dental practitioners, microbiome analysis offers potential to identify at-risk patients before clinical symptoms emerge. Understanding an individual’s microbial profile can guide personalized interventions such as targeted antimicrobial therapies, probiotic supplementation, or dietary modifications designed to restore microbial balance. Microbiome analysis in patients with age-related salivary hypofunction reveals distinct microbial ecosystem alterations that may guide targeted interventions. Some patients may benefit from probiotic supplementation designed to restore protective commensal bacteria, while others may require antifungal therapy or customized saliva substitutes. Shown in Box 1 are some of the strategies that could be implemented to address oral-systemic health connections.
Like what you’re learning? Download a brochure for our Geriatric Dentistry Master Program certificate or master’s degree program.
Salivary Biomarkers
Saliva has emerged as an invaluable diagnostic fluid, offering non-invasive, easily collected biological samples rich in diagnostic information. For geriatric patients—particularly those who are frail, cognitively impaired, or have difficulty tolerating traditional procedures—salivary diagnostics represent a patient-centered alternative.
Salivary biomarkers provide real-time information about inflammatory status, tissue destruction, and disease activity. In periodontal disease, biomarkers such as matrix metalloproteinase-8 (MMP-8), interleukin-1 beta (IL-1β), and RANKL demonstrate strong correlations with disease severity and progression. Recent research identifies enhanced diagnostic accuracy through novel protein biomarker profiles distinguishing between different disease stages with greater precision than traditional clinical assessments.
Point-of-care salivary testing devices are becoming available, allowing chairside analysis that informs immediate treatment decisions. Elevated MMP-8 levels can indicate active periodontal breakdown even without obvious clinical signs, prompting more aggressive intervention. Conversely, biomarker profiles consistent with stable disease support more conservative maintenance approaches.
Treatment Implications
When salivary biomarker testing is available, elevated MMP-8 levels should prompt more frequent maintenance intervals and consideration of adjunctive therapies such as locally delivered antimicrobials or host modulation therapy. For patients with specific microbial profiles showing high levels of periodontal pathogens, targeted antimicrobial therapy can be selected based on microbial susceptibility testing, maximizing effectiveness while minimizing antibiotic resistance. Genetic testing for polymorphisms associated with hyperinflammatory responses identifies patients who may benefit from adjunctive host modulation therapy, such as low-dose doxycycline or omega-3 supplementation.
Artificial Intelligence and Clinical Decision Support
Artificial intelligence (AI) is revolutionizing how we analyze complex biological data and translate it into actionable insights. In precision oral health for older adults, AI offers powerful tools for risk stratification, early disease detection, and treatment optimization.
AI algorithms integrate diverse data streams—radiographic images, clinical parameters, genetic information, biomarker profiles, and electronic health records—to identify patterns that may escape human detection. AI-driven analysis of dental radiographs demonstrates ability to detect early periodontal bone loss with accuracy exceeding experienced clinicians, particularly valuable in geriatric populations where early intervention prevents progression to severe disease.
Machine learning models create personalized risk profiles accounting for complex factors affecting oral health in older adults. By analyzing data from thousands of patients, these models predict which individuals face highest risk for disease progression, tooth loss, or treatment complications, enabling proactive interventions. AI applications optimize periodontal maintenance recall intervals based on individual risk factors rather than arbitrary time frames.
Treatment Implications
AI-powered decision support systems are becoming more accessible through integration with practice management software and digital radiography platforms. Practitioners should familiarize themselves with AI-enhanced diagnostic tools for early detection of periodontal bone loss and caries. When available, AI-generated risk profiles can inform individualized maintenance intervals, moving away from standardized 3- or 6-month recalls toward personalized schedules based on disease activity, biomarker levels, and systemic risk factors. For high-risk patients identified through AI analysis, more aggressive preventive protocols should be implemented, including more frequent professional interventions and enhanced home care instruction.
Implementation Considerations
While the potential of precision medicine in geriatric oral health is substantial, implementation challenges must be addressed. Most dental practices currently lack the equipment, information systems, and trained personnel necessary to collect, analyze, and interpret complex biological data. Cost considerations cannot be overlooked. Advanced diagnostic testing, genetic analysis, and AI-powered decision support systems require investment that may not be offset by current reimbursement models.
Ethical considerations surrounding genetic testing and data privacy must be carefully navigated. Patients should be fully informed about implications of genetic testing, including potential psychological impacts and the importance of protecting sensitive genetic information. Interprofessional collaboration will be essential for integrating precision oral health strategies within broader geriatric care plans.
Despite these challenges, the trajectory is clear. Advances in technology are making precision medicine tools more accessible. Growing evidence bases demonstrate clinical utility and value. And patient expectations for personalized, proactive care continue to rise. Box 2 presents strategies for implementing precision medicine approaches in dental practice.
Summary
Precision medicine represents a fundamental shift in how we deliver oral healthcare to older adults. By moving beyond population averages to embrace individual biological variation, we can identify disease risk before symptoms emerge, select treatments most likely to succeed for each patient, and optimize outcomes while minimizing treatment burden.
For dental practitioners, precision medicine offers tools to address the inherent complexity of caring for older adults with multiple comorbidities and diverse functional statuses. The integration of genomics, microbiomics, salivary biomarkers, and artificial intelligence provides increasingly sophisticated capabilities for personalized care. Practitioners who embrace these innovations and develop relevant competencies will be best positioned to deliver the highest quality care to our aging population.
Postgraduate Geriatric Dentistry
Are you looking for improved ways to diagnose, treat, and manage the oral healthcare of older patients? Explore our online master’s and certificate program in Geriatric Dentistry.
References:
1. Roman YM, Dixon DL, Salgado TM, Price ET, Zimmerman KM, Sargent L, Slattum PW. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation. Pharmacogenomics. 2020 Jun;21(9):627-635.
2. Ren Y, Chen M, Wang Z, Han JD. Oral microbiota in aging and diseases. Life Med. 2024 Jun 28;3(3):lnae024.
3. Rajasekaran JJ, Krishnamurthy HK, Bosco J, Jayaraman V, Krishna K, Wang T, Bei K. Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. Microorganisms. 2024 Aug 29;12(9):1797.
4. Deng L, Guan G, Cannon RD, Mei L. Age-related oral microbiota dysbiosis and systemic diseases. Microb Pathog. 2025 Aug;205:107717
5. Domokos Z, Simon F, Uhrin E, Szabó B, Váncsa S, Varga G, Hegyi P, Kerémi B, Németh O. Evaluating salivary MMP-8 as a biomarker for periodontal diseases: A systematic review and meta-analysis. Heliyon. 2024 Nov 14;10(22):e40402.
6. Boynes SG, Sofiyeva N, Saw T, Nieto V, Palomo L. Assessment of salivary matrix metalloproteinase (MMP8) and activated salivary matrix metalloproteinase (aMMP8) in periodontitis patients: a systematic review and meta-analysis. Front Oral Health. 2025 Feb 19;6:1444399
7. Jundaeng J, Chamchong R, Nithikathkul C. Artificial intelligence-powered innovations in periodontal diagnosis: a new era in dental healthcare. Front Med Technol. 2025 Jan 10;6:1469852.
8. Sarakbi RM, Varma SR, Annamma LM Sivaswamy V. Implications of artificial intelligence in periodontal treatment maintenance: a scoping review. Front Oral Health. 2025 May14:6:1561128.
